150P Phase I/IIa trial of CD200R1 inhibitor 23ME-00610: Exploratory analyses of tissue-based and genetic biomarkers. - Razak, A.R. Abdul; Naing, A.; Diep, A.N.; Hwang, C.C.; Reisetter, A.C.; Fuller, Z.L.; Hom, C.; Glatt, D.M.; Schmidt, M. (Annals of Oncology, 2024)